→
Stock Comparison
Side-by-side fundamentals, valuation, and AI summaries for both tickers.
UNH
UNITEDHEALTH GROUP INC
UnitedHealth Group Inc has a market capitalization of $383.56B and is currently trading at $421.03, reflecting a day range of $415.88 to $421.89. The company's P/E ratio is 31.82, while revenue growth year-over-year stands at 11.81%, despite an EPS growth decline of 14.70%. The dividend yield is 2.06%, and the stock has a 52-week high of $461 and a low of $235.
Investors should consider both the growth potential and profitability challenges when evaluating UnitedHealth Group's stock.
JNJ
Johnson & Johnson
Johnson & Johnson has a market capitalization of $660.63B and a current stock price of $271.93, reflecting a day range between $269.85 and $274.84. The company's P/E ratio stands at 24.65, with an impressive EPS growth of 90.50% year-over-year, while revenue growth is recorded at 6.05%. The stock's 52-week high is $275 and the low is $164.04.
Investors should consider both the growth opportunities and legal risks associated with Johnson & Johnson's operations.
UNH
Bull Case
Some investors cite UnitedHealth's revenue growth of 11.81% year-over-year as a positive indicator of its market strength. Additionally, the company's robust market cap of $383.56B suggests a strong presence in the healthcare sector.
Bear Case
Conversely, the decline in EPS growth by 14.70% raises concerns about profitability trends. The P/E ratio of 31.82 may also indicate that the stock is valued at a premium compared to its earnings.
JNJ
Bull Case
Some investors cite Johnson & Johnson's robust EPS growth of 90.50% year-over-year as a sign of strong operational performance. Additionally, the company's return on equity (ROE) stands at 32.87%, indicating effective management and profitability.
Bear Case
Concerns arise from Johnson & Johnson's legal battles, with a proposed $5.5B settlement related to talc baby powder lawsuits potentially impacting its financials. Furthermore, the stock's P/E ratio of 24.65 may suggest overvaluation compared to industry peers.
UNITEDHEALTH GROUP INC: UnitedHealth Group Inc has a market capitalization of $383.56B and is currently trading at $421.03, reflecting a day range of $415.88 to $421.89. The company's P/E ratio is 31.82, while revenue growth year-over-year stands at 11.81%, despite an EPS growth decline of 14.70%. The dividend yield is 2.06%, and the stock has a 52-week high of $461 and a low of $235. Johnson & Johnson: Johnson & Johnson has a market capitalization of $660.63B and a current stock price of $271.93, reflecting a day range between $269.85 and $274.84. The company's P/E ratio stands at 24.65, with an impressive EPS growth of 90.50% year-over-year, while revenue growth is recorded at 6.05%. The stock's 52-week high is $275 and the low is $164.04.
UNITEDHEALTH GROUP INC: Some investors cite UnitedHealth's revenue growth of 11.81% year-over-year as a positive indicator of its market strength. Additionally, the company's robust market cap of $383.56B suggests a strong presence in the healthcare sector. Johnson & Johnson: Some investors cite Johnson & Johnson's robust EPS growth of 90.50% year-over-year as a sign of strong operational performance. Additionally, the company's return on equity (ROE) stands at 32.87%, indicating effective management and profitability.
UNITEDHEALTH GROUP INC risks: Conversely, the decline in EPS growth by 14.70% raises concerns about profitability trends. The P/E ratio of 31.82 may also indicate that the stock is valued at a premium compared to its earnings. Johnson & Johnson risks: Concerns arise from Johnson & Johnson's legal battles, with a proposed $5.5B settlement related to talc baby powder lawsuits potentially impacting its financials. Furthermore, the stock's P/E ratio of 24.65 may suggest overvaluation compared to industry peers.
AI-powered portfolio intelligence, daily briefs, and real-time monitoring for every stock you own.
Not financial advice. Informational use only. AI-generated content may contain errors. Consult a licensed financial advisor before making investment decisions.